{"id":"tp-56295","type":"article-newspaper","title":"Arrowhead Targets U.S. REDEMPLO Launch for Q2 2027, Subject to FDA Approval","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/56295","datePublished":"2026-11-13T04:13:05.000Z","dateModified":"2026-11-13T04:13:05.000Z","language":"en","abstract":"The company reiterated a $3 billion to $4 billion U.S. sales opportunity and said it is too early to provide sales guidance.","section":"Business","references":[{"title":"fiscal year-end results","url":"https://www.tokenpost.com/news/business/55995"}]}